30.04.2019
- Eli Lilly is collaborating with Avidity Biosciences to discover, develop and commercialize potential new medicines in immunology and other select indications. The companies will...
08.04.2019
- The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious...
06.03.2019
- Under the name Insulin Lispro, US drugmaker Eli Lilly plans to sell a generic version of its rapid-acting insulin Humalog. It will be priced 50% below the name-brand product, which...
09.01.2019
- In the latest move by “big pharma” to buy into cancer-focused biotechs, US drugmaker Eli Lilly is acquiring Loxo Oncology for about $8 billion in cash. The plans were announced on...
02.11.2018
- Paolo Magri, senior vice president, business development at Advitech, has been elected president of the Drug, Chemical & Associated Technologies Association (DCAT). Also elected to...
02.10.2018
- Eli Lilly has entered into an agreement with Chugai Pharmaceutical for the Japanese drugmaker’s oral non-peptidic GLP-1 receptor agonist OWL833, which is currently being developed...
29.07.2018
- Eli Lilly has announced plans to spin off its Elanco animal health business, ending months of uncertainty. The US drugmaker said it will file a registration in the coming weeks...
17.05.2018
- US drugmaker Eli Lilly has agreed to buy Canada’s AurKa Pharma from TVM Capital Life Science, bringing back in-house experimental cancer drug AK-01. The drug, an Aurora kinase A...